Merck invests € 300 million in new Life Science production site in South Korea
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
The pilot plant is focused on scaling up beverage production and will support applications
To accelerate the development of next-generation radioconjugates to treat cancer
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
These re-agent and diagnostic test kits come with 99.7% accuracy
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
Subscribe To Our Newsletter & Stay Updated